Research and Development Scientist, Next-Generation Sequencing

Job overview

The Research and Development Scientist, Next-Generation Sequencing role is onsite in Somerville, MA, with an annual salary range of $95,000–$125,000 and a 10% bonus opportunity. Predicta Biosciences is developing molecular insights for blood cancer care to support clinicians and researchers. The scientist develops and optimizes genomic assays that characterize tumor and immune cells, translating research concepts into clinical assays. The work connects laboratory workflows with computational analysis and supports improved blood-based cancer diagnostic capabilities.

What you'll do

• Design and optimize NGS assays and workflows, including whole genome sequencing and single-cell RNA sequencing
• optimize low-input library preparation
• oversee Illumina sequencing run planning, pooling, and loading
• evaluate technologies and reagents
• establish quality metrics and validation practices
• collaborate with R&D and computational biology
• document SOPs, protocols, and technical reports
• maintain reproducible records
• mentor junior scientists
• support technology transfer into product development and clinical operations as needed.

What we're looking for

Skills & competencies

r&d scientist

next-generation sequencing

ngs assay development

genomics

molecular biology

single-cell rna-seq

blood cancer

somerville ma

predicta biosciences

$95k–$125k

10% bonus

illumina

Work arrangement

• Weekend coverage required

Benefits & perks

• Paid parking or T-pass stipend
• stock options
• flexible time off
• 401(k)
• medical, dental, and vision coverage
• partially company-funded HSA.

Why this role

Mission-driven blood cancer diagnostics work; annual salary range includes a 10% bonus opportunity. PhD or equivalent industry experience and at least five years of hands-on NGS assay development experience are specified.

About the employer

Predicta Biosciences is hiring for this role. Industry: Research and Development in Biotechnology (except Nanobiotechnology). Sector: 54.